S. Takeshita

发表

The Role of Neutrophil Activation in the Pathogenesis of Kawasaki Disease

S. Nonoyama, Takashi Kanai, Y. Kawamura, 2018 .

Ulinastatin, a Urinary Trypsin Inhibitor, for the Initial Treatment of Patients With Kawasaki Disease: A Retrospective Study

Hiroki Sato, Tomio Kobayashi, S. Nonoyama, 2011, Circulation.

Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease.

I. Sekine, K. Nakatani, H. Tsujimoto, 2002, Clinical immunology.

Circulating adiponectin levels in Kawasaki disease

N. Yoshida, S. Takeshita, H. Takabayashi, 2006, Acta paediatrica.

"A Comprehensive Overview of Risk Scoring Systems for Predicting Intravenous Immunoglobulin (IVIG)- Resistance in Kawasaki Disease"

S. Nonoyama, Takashi Kanai, Y. Kawamura, 2019, Advancements in Cardiovascular Research.

A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease

S. Nonoyama, Takashi Kanai, Y. Kawamura, 2017, PloS one.

Imbalance in the production between vascular endothelial growth factor and endostatin in Kawasaki disease

S. Nonoyama, Y. Kawamura, N. Yoshida, 2005, Clinical and experimental immunology.

Standard-dose and Short-term Corticosteroid Therapy in Immunoglobulin-resistant Kawasaki Disease

K. Nakatani, H. Tsujimoto, S. Takeshita, 2005, Clinical pediatrics.

Activation of mouse liver natural killer cells and NK1.1+T cells by bacterial superantigen‐primed Kupffer cells

S. Seki, I. Sekine, Y. Habu, 1999, Hepatology.

Intravenous immunoglobulin preparations promote apoptosis in lipopolysaccharide‐stimulated neutrophils via an oxygen‐dependent pathway in vitro

K. Nakatani, H. Tsujimoto, S. Takeshita, 2005, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Circulating Endothelial Cells in Kawasaki Disease

K. Nakatani, H. Tsujimoto, T. Tokutomi, 2003, Clinical and experimental immunology.

Inhibitory effect of serine protease inhibitors on neutrophil‐mediated endothelial cell injury

I. Sekine, K. Nakatani, S. Takeshita, 2001, Journal of leukocyte biology.

[Use of the urinary trypsin inhibitor ulinastatin for acute Kawasaki disease].

S. Nonoyama, Takashi Kanai, Y. Kawamura, 2014, Nihon rinsho. Japanese journal of clinical medicine.

Isolated Congenital Left Ventricular Diverticulum with Perinatal Dysrhythmia: A Case Report and Review of the Literature

K. Nakatani, H. Tsujimoto, Y. Kawamura, 2000, Pediatric Cardiology.

Studies of Peripheral Blood Toxic Neutrophils as a Predictor of Coronary Risk in Kawasaki Disease—the Pathogenetic Role of Hematopoietic Colony‐Stimulating Factors (GM‐CSF, G‐CSF)

T. Fujisawa, I. Sekine, S. Takeshita, 1990, Acta paediatrica Japonica : Overseas edition.

Increased production of serum IgA‐class antibody to lipid A in Kawasaki disease

I. Sekine, Maki Yoshida, S. Takeshita, 2002, Pediatrics international : official journal of the Japan Pediatric Society.

Urinary Lactate Dehydrogenase Activity and Its Isozyme Patterns in Kawasaki Disease

S. Nonoyama, Takashi Kanai, Y. Kawamura, 2017, International journal of pediatrics.

Enhanced formation of neutrophil extracellular traps in Kawasaki disease

S. Nonoyama, Takashi Kanai, Y. Kawamura, 2020, Pediatric Research.

Characteristic Profile of Intestinal Microflora in Kawasaki Disease

I. Sekine, K. Nakatani, H. Tsujimoto, 2002, Pediatric Research.

The combination of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as a novel predictor of intravenous immunoglobulin resistance in patients with Kawasaki disease: a multicenter study

S. Nonoyama, Keiji Kinoshita, Takashi Kanai, 2020, Heart and Vessels.

The Combined Usefulness of the Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Predicting Intravenous Immunoglobulin Resistance with Kawasaki Disease.

S. Nonoyama, Takashi Kanai, Y. Kawamura, 2016, The Journal of pediatrics.

High‐Dose Immunoglobulin for Juvenile Myasthenia Gravis

I. Sekine, S. Takeshita, S. Yoshioka, 1989, Acta paediatrica Japonica : Overseas edition.

Increased Levels of Lipopolysaccharide Binding Protein in Plasma in Children with Kawasaki Disease

I. Sekine, H. Tsujimoto, S. Takeshita, 2002, Clinical and Vaccine Immunology.

Inhibition of IL‐12 synthesis of peripheral blood mononuclear cells (PBMC) stimulated with a bacterial superantigen by pooled human immunoglobulin: implications for its effect on Kawasaki disease (KD)

Nakatani, Takata, H. Hiraide, 1998, Clinical and experimental immunology.

Intravenous immunoglobulin (IVIG) preparations induce apoptosis in TNF‐α‐stimulated endothelial cells via a mitochondria‐dependent pathway

I. Sekine, K. Nakatani, S. Takeshita, 2002, Clinical and experimental immunology.

Increased levels of circulating soluble CD14 in Kawasaki disease

Nakatani, Tsujimoto, K. Nakatani, 2000, Clinical and experimental immunology.

Interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) enhance lipopolysaccharide binding to neutrophils via CD14

I. Sekine, K. Nakatani, S. Takeshita, 1998, Inflammation Research.

Ulinastatin, a Urinary Trypsin Inhibitor, for the Initial Treatment of Patients With Kawasaki Disease: A Retrospective Study

Tomio Kobayashi, S. Nonoyama, Tohru Kobayashi, 2011, Circulation.